Skip to Content
chevron-left chevron-right chevron-up chevron-right chevron-left arrow-back star phone quote checkbox-checked search wrench info shield play connection mobile coin-dollar spoon-knife ticket pushpin location gift fire feed bubbles home heart calendar price-tag credit-card clock envelop facebook instagram twitter youtube pinterest yelp google reddit linkedin envelope bbb pinterest homeadvisor angies
Oct 13, 2025|El Paso Emergency Room

Flu’s Annoying Cousin Is Back: The RSV Update

Comprehensive Overview of RSV Update Fall 2025

virus under microscopeOverview of RSV

Respiratory Syncytial Virus (RSV) is a significant health concern, particularly as it stands as the leading cause of infant hospitalization in the U.S. [3]. The virus poses serious risks not only to babies but also to older adults who have underlying health conditions. As of September 2025, while RSV activity remains low, [hospitalizations](https://www.eper.As of September 19, 2025, respiratory illness levels are low, with COVID-19, influenza, and RSV activity declining, but hospitalizations remain elevated. Annually, RSV is responsible for between 60,000 to 160,000 hospitalizations and 6,000 to 10,000 deaths among older adults in the United States. The virus is most active between October and March, emphasizing the importance of vaccinations before this period to maximize protection. Additionally, infants born to vaccinated mothers tend to have a reduced risk of severe RSV disease, thanks to the transference of protective antibodies.

Current Statistics and Trends

RSV Cases and Hospitalizations

As of this fall, preliminary estimates of RSV cases are being tracked weekly, with cumulative data starting from October 1, 2025. The impact of RSV varies across different demographics, with infants being at higher risk for hospitalization. However, they generally have lower mortality rates compared to older adults. The Centers for Disease Control and Prevention (CDC) anticipates that the peak hospitalizations for COVID-19, influenza, and RSV will mirror those of the previous year. Data reveals a higher incidence of RSV cases in urban areas compared to rural settings. Efforts to increase awareness and vaccination are expected to positively affect hospitalization rates during the upcoming season.

Vaccine Recommendations and Developments

vaccine into armVaccination Guidelines

The CDC’s current RSV vaccine update recommends vaccinations for all adults aged 75 and older, as well as adults aged 50-75 with specific risk factors like lung disease, heart disease, and obesity. Three RSV vaccines are available this season: GSK’s Arexvy, Pfizer’s Abrysvo, and Moderna’s mResvia, all targeting the virus’s prefusion F protein. Furthermore, maternal vaccination with Abrysvo is recommended for pregnant individuals between 32-36 weeks gestation during the RSV season. Vaccination is ideally done from August to October to offer maximum immunity before the virus’s peak season. Moreover, infants under eight months old entering their first RSV season should receive monoclonal antibodies to ensure optimal protection.

Symptoms and Treatment Options

Identifying and Managing RSV

RSV symptoms often include coughing, wheezing, and difficulty breathing, which can be particularly severe in both infants and older adults. Treatment generally involves supportive care, focusing on adequate hydration and oxygenation. For infants, monoclonal antibodies such as Nirsevimab and Clesrovimab offer long-lasting protection against RSV. High-risk infants between 8-19 months old entering their second RSV season are advised to receive Nirsevimab. Healthcare providers should remain vigilant in monitoring RSV-positive patients for any signs of respiratory distress that may necessitate hospitalization.

baby productsPublic Health Strategies and Awareness

doctor looking into child's mouthPrevention and Education

Key public health strategies for RSV prevention include promoting hygiene practices and encouraging symptomatic individuals to wear masks to reduce transmission. The new monoclonal antibodies for infants are a proactive measure to prevent RSV-related hospitalizations and emergency visits. Vaccine hesitancy continues to be a challenge, with resources available to aid healthcare providers in effectively communicating the importance of immunizations to patients. Community outreach programs are crucial for educating families on RSV risks and prevention methods. Collaboration between healthcare providers and local health departments is essential to enhance awareness campaigns and vaccination efforts.

Importance of RSV Awareness and Education

Enhancing Public Understanding

Increasing awareness about RSV helps in tracking its impact and comparing it with other respiratory viruses like influenza and COVID-19. Campaigns focus on educating parents about the importance of vaccinating infants and pregnant individuals. Families are encouraged to adopt preventive measures against RSV, such as practicing hand hygiene and ensuring vaccination during pregnancy. Educational materials should be made available in multiple languages to effectively reach diverse communities. Social media platforms can be a powerful tool for spreading awareness about RSV symptoms and prevention strategies.

vaccine withdrawn from vialCall to Action for Proactive Health Measures

Encouraging Proactive Health Measures

El Paso Emergency Room is dedicated to offering expert care for RSV cases. We provide immediate treatment with state-of-the-art technology and compassionate staff. For more information on RSV updates and emergency care, visit El Paso Emergency Room’s website: eper.com.

What to Read Next
Back to the top